Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Summary

Exploratory, double-blind randomized, placebo-controlled, Phase II study to evaluate the effect(s) of short-term administration of liraglutide, a GLP-1R (glucagon-like peptide-1 receptor) agonist on joint and skin inflammation in patients with active Psoriatic Arthritis.

Timeline

Start

2015-05

Primary completion

2016-10

Completion

2016-10

Drugs

Indications